According to filings with the U.S. Securities and Exchange Commission, Ultralight is raised $9,300,000.00 in new Angel/Seed funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Ultralight
Ultralight is an AI-native software platform for modern medical practices focused on personalized, preventive care. The company brings together clinical data, workflows, and intelligence into a streamlined system, helping clinicians reduce administrative burden and improve patient care.

To learn more, visit https://www.ultralighthealth.com/
Linkedin Page: https://www.linkedin.com/company/ultralighthealth/

Contact:
Sunita Mohanty, Co-Founder
https://www.linkedin.com/in/sunita-mohanty/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.